Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pascal Edrich
Observed name:
P. Edrich
Institution:
Novartis (Switzerland)
Observed institutions:
Novartis (Switzerland),
Cincinnati Children's Hospital Medical Center,
Tzu Chi University,
UCB Pharma (Belgium)
OpenAlex ID:
A5032272771
A systematic review of the safety profile of levetiracetam: a new antiepileptic drug
2001
·
Jacqueline French
, Pascal Edrich
, et al.
·
Epilepsy Research
·
210
A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials
2003
·
J Cramer
, Katrien De Rue
, et al.
·
Epilepsy & Behavior
·
201
Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy
2003
·
Elinor Ben-Menachem
, Pascal Edrich
, et al.
·
Epilepsy Research
·
83
Efficacy and Safety of Levetiracetam (up to 2000 mg/day) in Taiwanese Patients with Refractory Partial Seizures: A Multicenter, Randomized, Double‐blind, Placebo‐controlled Study
2006
·
Jing‐Jane Tsai
, Der‐Jen Yen
, et al.
·
Epilepsia
·
77
Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: Analysis of two randomized, double-blind, placebo-controlled studies
2009
·
William E. Rosenfeld
, Selim Benbadis
, et al.
·
Epilepsy Research
·
58
Comparison of nilotinib and imatinib in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP): ENESTnd beyond one year.
2010
·
R. A. Larson
, P. D. le Coutre
, et al.
·
Journal of Clinical Oncology
·
38
Efficacy and safety of levetiracetam as adjunctive therapy in adult patients with uncontrolled partial epilepsy: The Asia SKATE II Study
2010
·
Patrick Kwan
, Shih-Hui Lim
, et al.
·
Epilepsy & Behavior
·
26
Measurement of seizure freedom in adjunctive therapy studies in refractory partial epilepsy: the levetiracetam experience
2006
·
Ilo Leppik
, Katrien De Rue
, et al.
·
Epileptic Disorders
·
24
Identifying baseline characteristics of placebo responders versus nonresponders in randomized double‐blind trials of refractory partial‐onset seizures
2006
·
Ida Niklson
, Pascal Edrich
, et al.
·
Epileptic Disorders
·
23
PDF
Decentralized Clinical Trials: Scientific Considerations Through the Lens of the Estimand Framework
2024
·
Rima Izem
, Emmanuel Zuber
, et al.
·
Therapeutic Innovation & Regulatory Science
·
19
PDF
The komet study: an open-label, randomized, parallel-group trial comparing the efficacy and safety of levetiracetam with sodium valproate and carbamazepine as monotherapy in subjects with newly diagnosed epilepsy
2008
·
Eugen Trinka
, Wim Van Paesschen
, et al.
·
Epilepsia
·
7
Medical and Neuro-oncology
2011
·
G. K. Prithviraj
, S. R. Sommers
, et al.
·
Neuro-Oncology
·
2
PDF
A Phase III Clinical Trial Program Investigating the Efficacy and Safety of Ianalumab in Patients with Primary Immune Thrombocytopenia (VAYHIT1 and VAYHIT2) and Warm Autoimmune Hemolytic Anemia (VAYHIA)
2023
·
Hanny Al-Samkari
, Wilma Barcellini
, et al.
·
Blood
·
1
PDF
Early Molecular Response (EMR) with Frontline Treatment Is a Significant Predictor of Long-Term BCR-ABL Transcript Levels in Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (CML) in Chronic Phase
2015
·
Giuseppe Saglio
, Sonya J. Snedecor
, et al.
·
Blood
·
1
Paediatric results from a multicenter, cross-sectional, non-interventional surveillance study (aESCAPE study) to evaluate the adverse effects of antiepileptic drug treatment in patients with epilepsy
2008
·
B. Steinborn
, S. Buyle
, et al.
·
European Journal of Paediatric Neurology
·
1
Ianalumab, an ADCC-Enhanced Anti-BAFF-Receptor Antibody, Has Beneficial Effects in an Active Mouse Model of Immune Thrombocytopenia (ITP)
2024
·
Johan Rebetz
, Genevieve Marcoux
, et al.
·
Blood
Increased Eligibility for Attempting Treatment-Free Remission (TFR) with Frontline Nilotinib (NIL) vs Imatinib (IM) in Patients with Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia (CML): Results of a Stochastic Simulation Model
2015
·
Francois-Xavier Mahon
, An Tran-Duy
, et al.
·
Blood
Everolimus treatment of subependymal giant cell astrocytomas (SEGA's) associated with tuberous sclerosis complex (TSC): the EXIST-I trial.
2011
·
Steven Sparagana
, Elena Belousova
, et al.
·
VUBIR (Vrije Universiteit Brussel)
Seizure freedom rates in different epilepsy populations treated with levetiracetam
2006
·
Josemir W. Sander
, TA Glauser
, et al.
·
UCL Discovery (University College London)
III F2 Levetiracetam in elderly patients with epilepsy
2002
·
Guenter Kraemer
, Pascal Edrich
·
日本てんかん学会プログラム・予稿集
Show more works
View as search
Works count:
20
Citation count:
771
H-index:
10
I10-index:
10
Year
Topic
Type